Nanoviricides Inc (NNVC)
1.1400 -0.0100 (-0.87%) 04/03/25 [NYSE Arca]
1.0100 x 100 1.1500 x 200
Realtime by (Cboe BZX)
1.0100 x 100 1.1500 x 200
Realtime - - (-) -
for Thu, Apr 3rd, 2025
Try Excel 
Watch
-
Add or delete the symbol from one or more Watchlists.
-
Create New Watchlist
This name already in use.
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 06-2024 | 06-2023 | 06-2022 | 06-2021 | 06-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 4,798 | 8,150 | 14,066 | 20,517 | 13,709 |
| TOTAL | $4,971 | $8,445 | $14,416 | $20,824 | $13,986 |
| Non-Current Assets | |||||
| PPE Net | 7,513 | 8,107 | 8,694 | 9,085 | 9,544 |
| Intangibles | 325 | 334 | 342 | 350 | 358 |
| Other Non-Current Assets | 15 | 14 | 43 | 4 | 26 |
| TOTAL | $7,852 | $8,455 | $9,079 | $9,439 | $9,929 |
| Total Assets | $12,823 | $16,900 | $23,495 | $30,262 | $23,914 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 95 | 95 | 63 |
| Accounts payable and accrued liabilities | 1,096 | 391 | 272 | 232 | 942 |
| Accrued Expenses | 263 | 144 | 46 | 24 | 69 |
| TOTAL | $1,359 | $534 | $413 | $351 | $2,156 |
| Non-Current Liabilities | |||||
| aiOther Non-Current Liabilities | 0 | 1,500 | 0 | 0 | 0 |
| TOTAL | $N/A | $1,500 | $N/A | $N/A | $N/A |
| Total Liabilities | $1,359 | $2,034 | $413 | $351 | $2,156 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 14,677 | 11,746 | 11,592 | 11,515 | 10,654 |
| Common Shares | 0 | 0 | 0 | 12 | 9 |
| Retained earnings | -139,375 | -131,081 | -122,492 | -114,385 | -105,563 |
| TOTAL | $11,464 | $14,866 | $23,082 | $29,911 | $21,758 |
| Total Liabilities And Equity | $12,823 | $16,900 | $23,495 | $30,262 | $23,914 |